Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Macquarie Group Limited ( (AU:MQG) ) has shared an update.
Macquarie Group Limited has announced that it has ceased to be a substantial holder in Australian Clinical Labs Limited. This change in holding reflects a shift in Macquarie’s investment strategy and may impact its influence on the company’s voting securities. The announcement signifies a potential realignment of Macquarie’s portfolio, which could have implications for its market positioning and stakeholder interests.
The most recent analyst rating on (AU:MQG) stock is a Hold with a A$191.00 price target. To see the full list of analyst forecasts on Macquarie Group Limited stock, see the AU:MQG Stock Forecast page.
More about Macquarie Group Limited
Macquarie Group Limited is a global financial services group providing a diverse range of services including asset management, banking, advisory, and risk and capital solutions across debt, equity, and commodities markets. The company operates in various sectors worldwide, focusing on delivering innovative solutions to clients and stakeholders.
Average Trading Volume: 756,116
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$79.04B
See more insights into MQG stock on TipRanks’ Stock Analysis page.